据彭博新闻社报道,在诺和诺德肥胖症交易后,礼来放弃了 CVS 为员工提供的药物计划

路透中文
Nov 12, 2025
据彭博新闻社报道,在<a href="https://laohu8.com/S/NVO">诺和诺德</a>肥胖症交易后,<a href="https://laohu8.com/S/LLY">礼来</a>放弃了 CVS 为员工提供的药物计划

路透11月12日 - 彭博新闻社周二援引知情人士的话报道,礼来LLY.N将放弃CVS HealthCVS.N为其员工提供的药物福利计划,因为CVS停止承保其减肥药,转而承保诺和诺德NOVOb.CO的一种竞争对手药物。

彭博社援引他们查看的一份文件称,从1月1日起,礼来公司医疗计划覆盖的员工将自动通过一家名为Rightway的私营药房福利管理公司加入药房福利保险。

路透无法立即核实彭博社的报道。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10